Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin H Antikörper

CCNH Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7180950
  • Target Alle Cyclin H (CCNH) Antikörper anzeigen
    Cyclin H (CCNH)
    Reaktivität
    • 90
    • 48
    • 29
    • 7
    • 6
    • 5
    • 5
    • 4
    • 4
    • 4
    • 2
    • 1
    • 1
    Human
    Wirt
    • 78
    • 14
    Kaninchen
    Klonalität
    • 70
    • 22
    Polyklonal
    Konjugat
    • 52
    • 7
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 1
    Dieser Cyclin H Antikörper ist unkonjugiert
    Applikation
    • 61
    • 37
    • 24
    • 20
    • 16
    • 7
    • 6
    • 6
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Kreuzreaktivität
    Human, Maus, Ratte
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    Synthesized peptide derived from Human Cyclin H around the non-phosphorylation site of T315.
    Isotyp
    IgG
    Top Product
    Discover our top product CCNH Primärantikörper
  • Applikationshinweise
    WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    Cyclin H (CCNH)
    Andere Bezeichnung
    CCNH (CCNH Produkte)
    Synonyme
    zgc:114132 antikoerper, cak antikoerper, p34 antikoerper, p37 antikoerper, Cych antikoerper, ACYPI004637 antikoerper, ccnh antikoerper, Cyclin-H antikoerper, 142767_at antikoerper, CG7405 antikoerper, Dmel\\CG7405 antikoerper, CAK antikoerper, 6330408H09Rik antikoerper, AI661354 antikoerper, AV102684 antikoerper, AW538719 antikoerper, ccnh-A antikoerper, cyclin H antikoerper, cyclin-H antikoerper, Cyclin H antikoerper, CYclin H antikoerper, cyclin H L homeolog antikoerper, CCNH antikoerper, ccnh antikoerper, LOC5577539 antikoerper, Cych antikoerper, CycH antikoerper, cyh-1 antikoerper, Ccnh antikoerper, ccnh.L antikoerper
    Hintergrund
    6330408H09Rik antibody, AI661354 antibody, AV102684 antibody, AW538719 antibody, CAK antibody, CAK complex subunit antibody, ccnh antibody, CCNH_HUMAN antibody, CDK activating kinase antibody, CDK activating kinase complex subunit antibody, Cyclin dependent kinase activating kinase antibody, cyclin dependent kinase activating kinase complex subunit antibody, Cyclin H antibody, Cyclin-H antibody, CyclinH antibody, MO15 associated protein antibody, MO15-associated protein antibody, p34 antibody, p36 antibody, p37 antibody
    UniProt
    P51946
    Pathways
    Zellzyklus, Mitotic G1-G1/S Phases, M Phase
Sie sind hier: